Oppenheimer initiated coverage of Corteva with a Perform rating and no price target. The analyst is bullish on Corteva’s "streamlined portfolio and refreshed management team," which the firm sees driving operational synergies and accelerated customer-driven innovation. However, an uncertain macro backdrop and valuation lead the firm to look for a better entry point.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CTVA:
- Pacific Biosciences announces new workflows developed with Corteva
- Corteva, Bunge, Chevron team to produce lower carbon winter canola
- Corteva downgraded to Mixed from Positive view at OTR Global
- Corteva Agriscience Completes Acquisitions of Symborg and Stoller
- Corteva announces commercial launch of Optimum GLY canola